Treatment of hyperproliferative diseases
Details for Australian Patent Application No. 2001278632 (hide)
International Classifications
Event Publications
27 November 2003 Assignment before Grant
University of Sheffield The application has been assigned to Molecular Skincare Limited
25 May 2006 Application Accepted
Published as AU-B-2001278632
21 September 2006 Standard Patent Sealed
1 February 2007 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 08 Jan 2007. Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden ACT 2606
21 June 2007 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 08 Jan 2007
7 August 2008 Alteration of Name
The name of the patentee has been altered to York Pharma (R&D) Limited 2002
21 April 2011 Assignment Registered
York Pharma (R&D) Limited The patent has been assigned to Vampex Limited
15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2001278633-Lipo- or amphiphilic scintillators and their use in assays
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser